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Abstract
Background: Rapid reviews have the potential to overcome a key barrier to the use of research evidence in
decision making, namely that of the lack of timely and relevant research. This rapid review of systematic reviews
and primary studies sought to answer the question: What are the best methodologies to enable a rapid review of
research evidence for evidence-informed decision making in health policy and practice?
Methods: This rapid review utilised systematic review methods and was conducted according to a pre-defined
protocol including clear inclusion criteria (PROSPERO registration: CRD42015015998). A comprehensive search
strategy was used, including published and grey literature, written in English, French, Portuguese or Spanish, from
2004 onwards. Eleven databases and two websites were searched. Two review authors independently applied the
eligibility criteria. Data extraction was done by one reviewer and checked by a second. The methodological quality
of included studies was assessed independently by two reviewers. A narrative summary of the results is presented.
Results: Five systematic reviews and one randomised controlled trial (RCT) that investigated methodologies for
rapid reviews met the inclusion criteria. None of the systematic reviews were of sufficient quality to allow firm
conclusions to be made. Thus, the findings need to be treated with caution. There is no agreed definition of rapid
reviews in the literature and no agreed methodology for conducting rapid reviews. While a wide range of
‘shortcuts’ are used to make rapid reviews faster than a full systematic review, the included studies found
little empirical evidence of their impact on the conclusions of either rapid or systematic reviews. There is
some evidence from the included RCT (that had a low risk of bias) that rapid reviews may improve clarity
and accessibility of research evidence for decision makers.
Conclusions: Greater care needs to be taken in improving the transparency of the methods used in rapid
review products. There is no evidence available to suggest that rapid reviews should not be done or that
they are misleading in any way. We offer an improved definition of rapid reviews to guide future research
as well as clearer guidance for policy and practice.
Keywords: Rapid reviews, Knowledge translation, Evidence-informed decision-making, Research uptake, Health
policy
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Background
In May 2005, the World Health Assembly called on
WHO Member States to “establish or strengthen mecha-
nisms to transfer knowledge in support of evidence-based
public health and healthcare delivery systems, and
evidence-based health-related policies” [1]. Knowledge
translation has been defined by WHO as: “the synthesis,
exchange, and application of knowledge by relevant
stakeholders to accelerate the benefits of global and local
innovation in strengthening health systems and improv-
ing people’s health” [2]. Knowledge translation seeks to
address the challenges to the use of scientific evidence
in order to close the gap between the evidence generated
and decisions being made.
To achieve better translation of knowledge from re-
search into policy and practice it is important to be
aware of the barriers and facilitators that influence the
use of research evidence in health policy and practice
decision making [3–8]. The most frequently reported
barriers to evidence uptake are poor access to good
quality relevant research and lack of timely and relevant
research output [7, 9]. The most frequently reported fa-
cilitators are collaboration between researchers and pol-
icymakers, improved relationships and skills [7], and
research that accords with the beliefs, values, interests
or practical goals and strategies of decision makers [10].
In relation to access to good quality relevant research,
systematic reviews are considered the gold standard and
these are used as a basis for products such as practice
guidelines, health technology assessments, and evidence
briefs for policy [11–14]. However, there is a growing
need to provide these evidence products faster and with
the needs of the decision-maker in mind, while also
maintaining credibility and technical quality. This should
help to overcome the barrier of lack of timely and rele-
vant research, thereby facilitating their use in decision
making. With this in mind, a range of methods for rapid
reviews of the research evidence have been developed
and put into practice [15–18]. These often include modi-
fications to systematic review methods to make them
faster than a full systematic review. Some examples of
modifications that have been made include (1) a more
targeted research question/reduced scope; (2) a reduced
list of sources searched, including limiting these to spe-
cialised sources (e.g. of systematic reviews, economic
evaluations); (3) articles searched in the English language
only; (4) reduced timeframe of search; (5) exclusion of
grey literature; (7) use of search tools that make it easier
to find literature; and (7) use of only one reviewer for
study selection and/or data extraction. Given the emer-
gence of this approach, it is important to develop a
knowledge base regarding the implications of such
‘shortcuts’ on the strength of evidence being delivered to
decision makers. At the time of conducting this review,
we were not aware of any high quality systematic reviews
on rapid reviews and their methods.
It is important to note that a range of terms have been
used to describe rapid reviews of the research evidence, in-
cluding evidence summaries, rapid reviews, rapid syntheses,
and brief reviews, with no clear definitions [15, 16, 18–22].
In this paper, we have used the term ‘rapid review’, despite
starting with the term ‘rapid evidence synthesis’ in our
protocol, as it became clear during the conduct of our re-
view that it is the most widely used term in the literature
[23]. We consider a broad range of rapid reviews, including
rapid reviews of effectiveness, problem definition, aetiology,
diagnostic tests, and reviews of cost and cost-effectiveness.
The rapid review presented in this article is part of a
larger project aimed at designing a rapid response pro-
gram to support evidence-informed decision making in
health policy and practice [24]. The expectation is that a
rapid response will facilitate the use of research for deci-
sion making. We have labelled this study as a rapid re-
view because it was conducted in a limited timeframe
and with the needs of health policy decision-makers in
mind. It was commissioned by policy decision-makers
for their immediate use.
The objective of this rapid review was to use the best
available evidence to answer the following research
question: What are the best methodologies to enable a
rapid review of research evidence for evidence-informed
decision making in health policy and practice? Both sys-
tematic reviews and primary studies were included. Note
that we have deliberately used the term ‘best methodolo-
gies’ as it is likely that a variety of methods will be
needed depending on the research question, timeframe
and needs of the decision maker.
Methods
This rapid review used systematic review methodology and
adheres to the Preferred Reporting Items for Systematic
Reviews and Meta-Analysis statement [25]. A systematic re-
view protocol was written and registered prior to undertak-
ing the searches [26]. Deviations from the protocol are
listed in Additional file 1.
Inclusion criteria for studies
Studies were selected based on the inclusion criteria
stated below.
Types of studies
Both systematic reviews and primary studies were sought.
For inclusion, priority was given to systematic reviews and
to primary studies that used one of the following designs:
(1) individual or cluster randomised controlled trials (RCTs)
and quasi-randomised controlled trials; (2) controlled be-
fore and after studies where participants are allocated to
control and intervention groups using non-randomised
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methods; (3) interrupted time series with before and after
measurements (and preferably with at least three mea-
sures); and (4) cost-effectiveness/cost-utility/cost-benefit.
Other types of studies were also identified for consid-
eration for inclusion in case no systematic reviews
and few primary studies with strong study designs (as
indicated above in 1–4) could be found. They were
initially selected provided that they described some
type of evaluation of methodologies for rapid reviews.
Types of participants
Apart from needing to be within the field of health pol-
icy and practice, the types of participants were not re-
stricted, and the level of analysis could be at the level of
the individual, organisation, system or geographical area.
During the study selection process, we made a decision
to also include ‘products’, i.e. papers that include rapid
reviews as the unit of inclusion rather than people.
Types of articles/interventions
Studies that evaluated methodologies or approaches to
rapid reviews for health policy and/or practice, including
systematic reviews, practice guidelines, technology as-
sessments, and evidence briefs for policy, were included.
Types of comparisons
Suitable comparisons (where relevant to the article type)
included no intervention, another intervention, or current
practice.
Types of outcome measures
Relevant outcome measures included time to complete;
resources required to complete (e.g. cost, personnel);
measures of synthesis quality; measures of efficiency of
methods (measures that combine aspects of quality with
time to complete, e.g. limiting data extraction to key
characteristics and results that may reduce the time
needed to complete without impacting on review qual-
ity); satisfaction with methods and products; and imple-
mentation. During the study selection process the
authors agreed to include two additional outcomes that
were not in the published protocol but important for the
review, namely comparison of findings between the dif-
ferent synthesis methods (e.g. rapid vs. systematic re-
view) and cost-effectiveness.
Publications in English, French, Portuguese or Spanish,
from any country and published from 2004 onwards
were included. The year 2004 was chosen as this is the
year of the Mexico Ministerial Summit on Health Re-
search, where the know-do gap was first given serious
attention by health ministers [27]. Both grey and peer-
reviewed literature was sought and included.
Search methods for identification of studies
A comprehensive search of eleven databases and two
websites was conducted. The databases searched were
CINAHL, the Cochrane Library (including Cochrane Re-
views, the Database of Abstracts of Reviews of Effective-
ness, the Health Technology Assessment database, NHS
Economic Evaluation Database, and the database of
Methods Studies), EconLit, EMBASE, Health Systems
Evidence, LILACS and Medline. The websites searched
were Google and Google Scholar.
Grey literature and manual search
Some of the selected databases index a combination of
published and unpublished studies (for example, doc-
toral dissertations, conference abstracts and unpublished
reports); therefore, unpublished studies were partially
captured through the electronic search process. In
addition, Google and Google Scholar were searched. The
authors’ own databases of knowledge translation litera-
ture were also searched by hand for relevant studies.
The reference list of each included study was searched.
Contact was made with nine key authors and experts in
the area for further studies, of whom five responded.
Search strategy
Searches were conducted between 15th January and 3rd
February 2015 and supplementary searches (reference
lists, contact with authors) were conducted in May 2015.
Databases were searched using the keywords: “rapid lit-
erature review*” OR “rapid systematic review*” or “rapid
scoping review*” OR “rapid review*” OR “rapid ap-
proach*” OR “rapid synthesis” OR “rapid syntheses” OR
“rapid evidence assess*” OR “evidence summar*” OR
“realist review*” OR “realist synthesis” OR “realist syn-
theses” OR “realist evaluation” OR “meta-method*” OR
“meta method*” OR “realist approach*” OR “meta-evalu-
ation*” OR “meta evaluation*”. Keywords were searched
for in title and abstract, except where otherwise stated in
Additional file 2. Results were downloaded into the End-
Note reference management program (version X7) and
duplicates removed. The Internet search utilised the
search terms: “rapid review”; “rapid systematic review”;
“realist review”; “rapid synthesis”; and “rapid evidence”.
Screening and selection of studies
Searches were conducted and screened according to the
selection criteria by one review author (MH). The full
text of any potentially relevant papers was retrieved for
closer examination. This reviewer erred on the side of
inclusion where there was any doubt about its inclusion
to ensure no potentially relevant papers were missed.
The inclusion criteria were then applied against the full
text version of the papers (where available) independ-
ently by two reviewers (MH and RC). For studies in
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Portuguese and Spanish, other authors (EC, LR or JB)
played the role of second reviewer. Disagreements re-
garding eligibility of studies were resolved by discussion
and consensus. Where the two reviewers were still un-
certain about inclusion, the other reviewers (EC, LR, JB,
JL) were asked to provide input to reach consensus. All
studies which initially appeared to meet the inclusion
criteria, but on inspection of the full text paper did not,
were detailed in a table ‘Characteristics of excluded
systematic reviews,’ together with reasons for their
exclusion.
Application of the inclusion criteria by the two re-
viewers was performed as follows. First, all studies that
met the inclusion criteria for participants, interventions
and outcomes were selected, providing that they de-
scribed some type of evaluation of methodologies for
rapid evidence synthesis. At this stage, the study type
was assessed and categorised by the two reviewers as be-
ing a (1) systematic review; (2) primary study with a
strong study design, i.e. of one of the four types identi-
fied above; or (3) ‘other’ study design (that provided
some type of evaluation of methodologies for rapid evi-
dence synthesis). The reason for this was to enable the
reviewers to make a decision as to which study designs
should be included (based on available evidence, it was
not known if sufficient evidence would be found if only
systematic reviews and primary studies with strong study
designs were included from the outset) and because of
interest from the funders in other study types. Following
discussion between all co-authors it was decided that it
was likely that sufficient evidence could be provided
from the first two categories of study type. Thus, the
third group was excluded from data extraction but are
listed in Additional file 3.
Data extraction
Information extracted from studies and reviewed in-
cluded objectives, target population, method/s tested,
outcomes reported, country of study/studies and results.
For systematic reviews we also extracted the date of last
search, the included study designs and the number of
studies. For primary studies, we also extracted the year
of study, the study design and the population size. Data
extraction was performed by one reviewer (MH) and
checked by a second reviewer (RC). Disagreements were
resolved through discussion and consensus.
Assessment of methodological quality
The methodological quality of included studies was
assessed independently by two reviewers using AMSTAR:
A MeaSurement Tool to Assess Reviews [28] for system-
atic reviews and the Cochrane Risk of Bias Tool for RCTs
[29]. Disagreements in scoring were resolved by discussion
and consensus. For this review, systematic reviews that
achieved AMSTAR scores of 8 to 11 were considered high
quality; scores of 4 to 7 medium quality; and scores of 0 to
3 low quality. These cut-offs are commonly used in
Cochrane Collaboration overviews. The study quality as-
sessment was used to interpret their results when synthe-
sised in this review and in the formulation of conclusions.
Data analysis
Findings from the included publications were synthesised
using tables and a narrative summary. Meta-analysis was
not possible because the included studies were heteroge-
neous in terms of the populations, methods and outcomes
tested.
Results
Search results
Five systematic reviews (from seven articles) [18, 19, 21,
30–33] and one primary study with a strong study design –
a RCT [34] – met the inclusion criteria for the review. The
selection process for studies and the numbers at each stage
are shown in Fig. 1. The reasons for exclusion of the 75 pa-
pers at full text stage are shown in Additional file 3. The 12
evaluation studies excluded from data extraction due to
weak study designs are also listed at the end of Additional
file 3.
Characteristics of included studies and quality assessment
Characteristics of the included systematic reviews are
summarised in Table 1, with full details provided in
Additional file 4. All rapid reviews were targeted at
healthcare decision makers and/or agencies conducting
rapid reviews (including rapid health technology assess-
ments). Only two of the systematic reviews offered a def-
inition of “rapid review” to guide their reviews [19, 30, 33].
Three of the systematic reviews obtained samples of
rapid review products – though not necessarily randomly
– and examined aspects of the methods used in their
production [18, 19, 21]. Three of the systematic reviews
reviewed articles on rapid review methods [18, 30, 32].
Two of these also included a comparison of findings from
rapid reviews and systematic reviews conducted for the
same topic [18, 32].
None of the systematic reviews that were identified
examined the outcomes of resources required to complete,
synthesis quality, efficiency of methods, satisfaction
with methods and products, implementation, or cost-
effectiveness. However, while not explicitly assessing syn-
thesis/review quality, all of the reviews did report the
methods used to conduct the rapid reviews. We have re-
ported these details as they give an indication of the qual-
ity of the review. Therefore, the outcomes reported in the
included systematic reviews and recorded in Table 1 and
Additional file 4 do not align perfectly with those proposed
in our inclusion criteria. In addition, we have included
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some information that was not pre-defined but for which
we extracted information because it provided important
contextual information, e.g. type of product, definition,
rapid review initiation and rationale, nomenclature, and
content. The reporting of the results was also further com-
plicated by the use of a narrative, rather than a quantitative,
synthesis of the results in the included studies.
It is not possible to say how many unique studies are
included in these systematic reviews because only one
review actually included a list of included studies [30]
and one a characteristics of included studies table (but
not in a form that was easy to use) [21]. However, it is
clear that there is likely to be significant overlap in stud-
ies between reviews. For example, the most recent
Fig. 1 Study selection flow chart – Methods for rapid reviews
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systematic review by Hartling et al. [31, 32] also included
the four previous systematic reviews included in this
rapid review [18, 19, 21, 30, 33].
The RCT was targeted at healthcare professionals in-
volved in clinical guideline development [34]. It aimed to
assess the effectiveness of different evidence summary for-
mats for use in clinical guideline development. Three dif-
ferent packs were tested – pack A: a systematic review
alone; pack B: a systematic review with summary-of-
findings tables included; and pack C: an evidence synthesis
and systematic review. Pack C is described by the authors
of the study as: “a locally prepared, short, contextually
framed, narrative report in which the results of the system-
atic review (and other evidence where relevant) were de-
scribed and locally relevant factors that could influence
the implementation of evidence-based guideline recom-
mendations (e.g. resource capacity) were highlighted” [34].
We interpreted pack C as being a ‘rapid review’ for the
purposes of this review as the authors state that it is based
on a comprehensive search and critical appraisal of the
best currently available literature, which included a
Cochrane review, an overview of systematic reviews and
RCTs, and additional RCTs but was likely to have been
done in a short timeframe. It was also conducted to help
improve decision-making. The primary outcome mea-
sured was the proportion of correct responses to key
clinical questions, whilst the secondary outcome was a
composite score comprised of clarity of presentation and
ease of locating the quality of evidence [34]. This study
was not included in any previous systematic reviews.
Four of the systematic reviews obtained AMSTAR
scores of 2 (low quality) and one a score of 4 (medium
quality). No high quality systematic reviews were found.
Thus, the findings of the systematic reviews should be
taken as indicative only and no firm conclusions can be
made. The RCT was classified as low risk of bias on the
Cochrane Risk of Bias tool. The quality assessments can
be found in Additional file 5.
Findings
Definition of a ‘rapid review’
The five systematic reviews are consistent in stating that
there is no agreed definition of rapid reviews and no
agreed methodology for conducting rapid reviews [18,
19, 21, 30–33]. According to the authors of one review:
“the term ‘rapid review’ does not appear to have one sin-
gle definition but is framed in the literature as utilizing
various stipulated time frames between 1 and 6 months”
[21, p. 398]. The definitions offered to guide the reviews
by Abrami et al. [19] and Cameron et al. [30] both use a
timeframe of up to 6 months (Table 1). Cameron et al.
[30] also include in their definition the requirement that
the review contains the elements of a comprehensive
search – though they do not offer criteria to assess this.
Table 1 Characteristics of the included systematic reviews. Reviews are ordered chronologically, from most to least recent, and
alphabetically within years
Systematic review Target population Method/s tested Included study designs
and number
Outcomes reported AMSTAR
score
Featherstone et al.,
2015 [31]; Hartling et al.,
2015 [32]
Healthcare
decision makers
RR – not clearly defined 53 articles: 8 background
articles; 3 studies with
empiric data; 12 reviews
of RR types; 30 articles on
RR methods
Type of product;
Methods useda;
Comparison of RRs and
SRs
4
Harker & Kleijnen,
2012 [21]
Those making HTA
assessments in healthcare
RRs of HTAs 46 full RRs; 3 summaries
of RRs
Methods used; Time to
complete
2
Abrami et al., 2010 [19] Policy-makers and
practitioners
RRs – defined as a review
completed in a timely fashion
(i.e. within 6 months) or
defined by the authors
as such
42 RRs Methods used 2
Ganann et al., 2010 [18] Health system planners
and policymakers
RRs – undefined 25 RRs; 45 methods
articles
Nomenclature; Methods
used; Comparison of RRs
and SRs; Implications of
methods used
2
Cameron et al., 2007 [30];
Watt et al., 2008 [33]
HTA agencies and users RR, defined as a HTA report
or SR that has taken between
1 and 6 months to produce,
which contains the elements
of a comprehensive literature
search
12 studies: 1 guideline
(abstract); 3 program
evaluations; 2 comparative
studies; 2 methods studies;
3 commentaries; 1 survey
RR initiation and
rationale; Methods used;
Content; Time to
complete; Dissemination
and impact; Peer review
procedures; Quality
evaluation of the RR
2
aThe outcome ‘methods used’ refers to the method used in the included rapid reviews. This outcome is important for determining the quality of the review
HTA health technology assessment, RR rapid review, SR systematic review
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Abrami et al. [19] use the term ‘brief review’ rather
than ‘rapid review’ to emphasise that both timeframe
and scope may be affected. They write that “a brief re-
view is an examination of empirical evidence that is lim-
ited in its timeframe (e.g. six months or less to complete)
and/or its scope, where scope may include:
 the breadth of the question being explored (e.g. a
review of one-to-one laptop programs versus a review
of technology integration in schools);
 the timeliness of the evidence included (e.g. the last
several years of research versus no time limits);
 the geographic boundaries of the evidence (e.g.
inclusion of regional or national studies only versus
international evidence);
 the depth and detail of analyses (e.g. reporting only
overall findings versus also exploring variability
among the findings); or
 otherwise more restrictive study inclusion criteria
than might be seen in a comprehensive review.” [19,
p. 372].
All other included systematic reviews used the term
‘rapid review’ or ‘rapid health technology assessment’ to
describe rapid reviews.
Methods used based on examples of rapid reviews
While the word ‘rapid’ indicates that it will be carried
out quickly, there is no consistency in published rapid
reviews as to how it is made rapid and which part, or
parts, of the review are carried out at a faster pace than
a full systematic review [18, 19, 21]. A further complex-
ity is the reporting of methods used in the rapid review,
with about 43% of the rapid reviews examined by
Abrami et al. [19] not describing their methodology
comprehensively. Three examples of ‘shortcuts’ taken
are (1) not using two reviewers for study selection and/
or data extraction; (2) not conducting a quality assess-
ment of included studies; and (3) not searching for grey
literature [18, 19, 21]. However, it is important to note
that the rapid reviews examined in these three system-
atic reviews were not necessarily selected randomly and,
thus, it is not possible to accurately quantify the propor-
tion of rapid reviews taking various ‘shortcuts’ and which
‘shortcuts’ are the most common. The time taken for the
reviews examined varied from several days to one year
[19]; 3 weeks to 6 months [18]; and 7–12 (mean 10.42,
SD 7.1) months [21].
Methods used based on studies of rapid review methods
Methodological approaches or ‘shortcuts’ used in rapid
reviews to make them faster than a full systematic re-
view include [18, 19, 32] limiting the number of ques-
tions; limiting the scope of questions; searching fewer
databases; limited use of grey literature; restricting the
types of studies included (e.g. English only, most recent
5 years); relying on existing systematic reviews; eliminat-
ing or limiting hand searching of reference lists and rele-
vant journals; narrow time frame for article retrieval;
using non-iterative search strategy; eliminating consult-
ation with experts; limiting full-text review; limiting dual
review for study selection, data extraction and/or quality
assessment; limiting data extraction; limiting risk of bias
assessment or grading; minimal evidence synthesis; pro-
viding minimal conclusions or recommendations; and
limiting external peer review. Harker et al. [21] found
that, with increasing timeframes, fewer of the ‘shortcuts’
were used and that, with longer timeframes, it was more
likely that risk of bias assessment, evidence grading and
external peer review would be conducted [21].
None of the included systematic reviews offer firm
guidelines for the methodology underpinning rapid re-
views. Rather, they report that many articles written
about rapid reviews offer only examples and discussion
surrounding the complexity of the area [30].
Supporting evidence for shortcuts
While authors of the included systematic reviews tend to
agree that changes to scope or timeframe can introduce
biases (e.g. selection bias, publication bias, language of
publication bias) they found little empirical evidence to
support or refute that claim [18, 19, 21, 30, 32].
The review by Ganann et al. [18] included 45 meth-
odological studies that considered issues such as the im-
pact of limiting the number of databases searched, hand
searching of reference lists and relevant journals, omit-
ting grey literature, only including studies published in
English, and omitting quality assessment. However, they
were unable to provide clear methodological guidelines
based on the findings of these studies.
Comparison of findings – rapid reviews versus systematic
reviews
A key question is whether the conclusions of a rapid re-
view are fundamentally different to a full systematic re-
view, i.e. whether they are sufficiently different to
change the resulting decision. This is an area where the
research is extremely limited. There are few comparisons
of full and rapid reviews that are available in the litera-
ture to be able to determine the impact of the above
methodological changes – only two primary studies were
reported in the included systematic reviews [35, 36]. It is
important to note that neither of these studies met, on
their own, the inclusion criteria for the review in that
they did not have a sufficiently strong study design. Both
are included in the list of 12 studies excluded from data
extraction (Fig. 1 and Additional file 3). Thus, they pro-
vide a very low level of evidence.
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One of the primary studies compared full and rapid
reviews on the topics of drug eluting stents, lung volume
reduction surgery, living donor liver transplantation and
hip resurfacing [30, 36]. There were no instances in
which the essential conclusions of the rapid and full re-
views were opposed [32]. The other compared a rapid
review with a full systematic review on the use of potato
peels for burns [35]. The results and conclusions of the
two reports were different. The authors of the rapid re-
view suggest that this is because the systematic review
was not of sufficiently good quality – as they missed two
important trials in their search [35]. However, the lim-
ited detail on the methods used to conduct the system-
atic review makes this case study of limited value.
Further research is needed in this area.
Impact of rapid syntheses on understanding of decision
makers
The included RCT by Opiyo et al. [34] examined the im-
pact of different evidence summary or synthesis formats
on knowledge of the evidence, with each participant re-
ceiving a pack containing three different summaries;
they found no differences between packs in the odds of
correct responses to key clinical questions. Pack C (the
rapid review) was associated with a higher mean com-
posite score for clarity and accessibility of information
about the quality of evidence for critical neonatal out-
comes compared to systematic reviews alone (pack A)
(adjusted mean difference 0.52, 95% confidence interval,
0.06–0.99). Findings from interviews with 16 panellists
indicated that short narrative evidence reports (pack C)
were preferred for the improved clarity of information
presentation and ease of use. The authors concluded
that their “findings suggest that ‘graded-entry’ evidence
summary formats may improve clarity and accessibility
of research evidence in clinical guideline development”
[34, p. 1].
Discussion
This review is the first high quality review (using system-
atic reviews as the gold standard for literature reviews)
published in the literature that provides a comprehensive
overview of the state of the rapid review literature. It
highlights the lack of definition, lack of defined methods
and lack of research evidence showing the implications
of methodological choices on the results of both rapid
reviews and systematic reviews. It also adds to the litera-
ture by offering clearer guidance for policy and practice
than has been offered in previous reviews (see Implica-
tions for policy and practice).
While five systematic reviews of methods for rapid re-
views were found, none of these were of sufficient qual-
ity to allow firm conclusions to be made. Thus, the
findings need to be treated with caution. There is no
agreed definition of rapid reviews in the literature and
no agreed methodology for conducting rapid reviews
[18, 19, 21, 30–33]. However, the systematic reviews in-
cluded in this review are consistent in stating that a
rapid review is generally conducted in a shorter time-
frame and may have a reduced scope. A wide range of
‘shortcuts’ are used to make rapid reviews faster than a
full systematic review. While authors of the included
systematic reviews tend to agree that changes to scope
or timeframe can introduce biases (e.g. selection bias,
publication bias, language of publication bias) they
found little empirical evidence to support or refute that
claim [18, 19, 21, 30, 32]. Further, there are few compari-
sons available in the literature of full and rapid reviews
to be able to determine the impact of these ‘shortcuts’.
There is some evidence from a good quality RCT with
low risk of bias that rapid reviews may improve clarity
and accessibility of research evidence for decision
makers [34], which is a unique finding from our review.
A scoping review published after our search found over
20 different names for rapid reviews, with the most fre-
quent term being ‘rapid review’, followed by ‘rapid evi-
dence assessment’ and ‘rapid systematic review’ [23]. An
associated international survey of rapid review producers
and modified Delphi approach counted 31 different names
[37]. With regards to rapid review methods and defini-
tions, the scoping review found 50 unique methods, with
16 methods occurring more than once [23]. For their
scoping review and international survey, Tricco et al. uti-
lised the working definition: “a rapid review is a type of
knowledge synthesis in which components of the systematic
review process are simplified or omitted to produce infor-
mation in a short period of time” [23, 37].
The authors of the most recent systematic review of
rapid review methods suggest that: “the similarity of
rapid products lies in their close relationship with the
end-user to meet decision making needs in a limited
timeframe” [32, p. vii]. They suggest that this feature
drives other differences, including the large range of
products often produced by rapid response groups, and
the wide variation in methods used [32] – even within
the same product type produced by the same group. We
suggest that this feature of rapid reviews needs to be
part of the definition and considered in future research
on rapid reviews, including whether it actually leads to
better uptake of research. To aid future research, we
propose the following definition: a rapid review is a type
of systematic review in which components of the sys-
tematic review process are simplified, omitted or made
more efficient in order to produce information in a
shorter period of time, preferably with minimal impact
on quality. Further, they involve a close relationship with
the end-user and are conducted with the needs of the
decision-maker in mind.
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When comparing rapid reviews to systematic reviews,
the confounding effects of quality of the methods used
must be considered. If rapid syntheses of research are
seen as systematic reviews performed faster and if sys-
tematic reviews are seen as the gold standard for evi-
dence synthesis, the quality of the review is likely to
depend on which ‘shortcuts’ were taken and this can be
assessed using available quality measures, e.g. AMSTAR
[28]. While Cochrane Collaboration systematic reviews
are consistently of a very high quality (achieving 10 or
11 on the AMSTAR scale, based on our own experience)
the same cannot be said for all systematic reviews that
can be found in the published literature or in databases
of systematic reviews – as is demonstrated by this review
where AMSTAR scores were quite low (Additional file 5)
and a related overview where AMSTAR scores varied
between two and ten [24, Additional file one]. This
fact has not been acknowledged in previous syntheses
of the rapid review literature. It is also possible for
rapid reviews to achieve high AMSTAR scores if con-
ducted and reported well. Therefore, it can be easily
argued that a high quality rapid review is likely to
provide an answer closer to the ‘truth’ than a systematic
review of low quality. It is also an argument for using
the same tool for assessing the quality of both sys-
tematic and rapid reviews.
Authors of the published systematic reviews of rapid
reviews suggest that, rather than focusing on developing
a formalised methodology, which may not be appropri-
ate, researchers and users should focus on increasing
the transparency of the methods used for each review
[18, 30, 33]. Indeed, several AMSTAR criteria are highly
dependent on the transparency of the write-up rather than
the methodology itself. For example, there are many ex-
amples of both systematic and rapid review authors not
stating that they used a protocol for their review when, in
fact, they did use one, leading to a loss of 1 point on the
AMSTAR scale. Another example is review authors failing
to provide an adequate description of the study selection
and data extraction process, thus making it hard for those
assessing the quality of the review to determine if this was
done in duplicate, which is again a loss of 1 point on the
AMSTAR scale.
While it could be argued that none of the included
reviews described their review as a systematic review,
we believe that it is appropriate to assess their quality
using the AMSTAR tool. This the best tool available,
to our knowledge, to assess and compare the quality
of review methods and considers the major potential
sources for bias in reviews of the literature [28, 38].
Further, the five reviews included were clearly not
narrative reviews as each described their methods, in-
cluding sources of studies, search terms and inclusion
criteria used.
Strengths and limitations
A key strength of this rapid review is the use of high
quality systematic review methodology, including the
consideration of the scientific quality of the included
studies in formulating conclusions. A meta-analysis was
not possible due to the heterogeneity in terms of inter-
vention types and populations studied in the included
systematic reviews. As a result publication bias could
not be assessed quantitatively in this review and no clear
methods are available for assessing publication bias
qualitatively [39]. Shortcuts taken to make this review
more rapid, as well as an AMSTAR assessment of the re-
view, are shown in Additional file 6. The AMSTAR as-
sessment is based on the published tool [28] and
additional guidance provided on the AMSTAR website
(http://amstar.ca/Amstar_Checklist.php).
The current rapid review is evidence that a review can
include several shortcuts and be produced in a relatively
short amount of time without sacrificing quality, as
shown by the high AMSTAR score (Additional file 6).
The time taken to complete this review was 7 months
from signing of contract (November 2014) to submission
of the final report to the funder (June 2015). Alterna-
tively, if publication of the protocol on PROSPERO and
the start of literature searching (January 2014) are taken
as the starting point, the time taken was 5 months.
Limitations of this review include (1) the low quality
of the systematic reviews found, with three of the four
included systematic reviews judged as low quality on the
AMSTAR criteria and the fourth just making it to
medium quality (Additional file 5); (2) the fact that few
primary studies were conducted in developing countries,
which is an issue for the generalisability of the results;
and (3) restricting the search to articles in English,
French, Spanish or Portuguese (languages with which
the review authors are competent) and to the last 10
years. However, this was done to expedite the review
process and is unlikely to have resulted in the loss of im-
portant evidence.
Implications for policy and practice
Users of rapid reviews should request an AMSTAR rat-
ing and a clear indication of the shortcuts taken to make
the review process faster. Producers of rapid reviews
should give greater consideration to the ‘write-up’ or
presentation of their reviews to make their review
methods more transparent and to enable a fair quality
assessment. This could be facilitated by including the ap-
propriate elements in templates and/or guidelines. If a
shorter report is required, the necessary detail could be
placed in appendices.
When deciding what methods and/or process to use
for their rapid reviews, producers of rapid reviews
should give priority to shortcuts that are unlikely to
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impact on the quality or risk of bias of the review. Ex-
amples include limiting the scope of the review [19],
limiting data extraction to key characteristics and results
[32], and restricting the study types included in the re-
view [32]. When planning the rapid review, the review
producer should explain to the user the implications of
any shortcuts taken to make the review faster, if any.
Producers of rapid reviews should consider maintain-
ing a larger highly skilled and experienced staff, who can
be mobilised quickly, and understands the type of prod-
ucts that might meet the needs of the decision maker
[19, 32]. Consideration should also be given to making
the process more efficient [19]. These measures can aid
timelines without compromising quality.
Implications for research
The impact on the results of rapid reviews (and system-
atic reviews) of any ‘shortcuts’ used requires further re-
search, including which ‘shortcuts’ have the greatest
impact on the review findings. Tricco et al. [23, 37] sug-
gest that this could be examined through a prospective
study that compares the results of rapid reviews to those
obtained through systematic reviews on the same topic.
However, to do this, it will be important to consider
quality as a confounding factor and ensure random se-
lection and blinding of the rapid review producers. If
random selection and blinding cannot be guaranteed, we
suggest that retrospective comparisons may be more ap-
propriate. Another, related approach, would be to com-
pare findings of reviews (be they systematic or rapid) for
each type of shortcut, controlling for methodological
quality. Other issues, such as the breadth of the inclu-
sion criteria used and number of studies included would
also need to be considered as possible confounding
factors.
The development of reporting guidelines for rapid re-
views, as are available for full systematic reviews, would
also help [18, 25]. These should be heavily based on sys-
tematic review guidelines but also consider characteris-
tics specific to rapid reviews such as the relationship
with the review user.
Finally, future studies and reviews should also address the
outcomes of review quality, satisfaction with methods and
products, implementation and cost-effectiveness as these
outcomes were not measured in any of the included studies
or reviews. Effectiveness of rapid reviews in increasing the
use of research evidence in policy decision-making is also
an important area for further research.
Conclusions
Care needs to be taken in interpreting the results of this
rapid review on the best methodologies for rapid review
given the limited state of the literature. There is a wide
range of methods currently used for rapid reviews and
wide range of products available. However, greater care
needs to be taken in improving the transparency of the
methods used in rapid review products to enable better
analysis of the implications of methodological ‘shortcuts’
taken for both rapid reviews and systematic reviews.
This requires the input of policymakers and practi-
tioners, as well as researchers. There is no evidence
available to suggest that rapid reviews should not be
done or that they are misleading in any way.
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